American Board of Family Medicine (ABFM) Practice Exam

Neuropathic pain is a complex, chronic pain state that typically requires a multi-faceted approach for effective management. Common treatments for neuropathic pain include medications that target nerve function and modulation of pain signals. Gabapentin and pregabalin are both anticonvulsants that have been found to be effective in alleviating neuropathic pain by stabilizing electrical activity in the nervous system and reducing the release of excitatory neurotransmitters. Amitriptyline, a tricyclic antidepressant, is also frequently used for neuropathic pain due to its ability to enhance pain relief through serotonin and norepinephrine reuptake inhibition, which can modify pain processing in the central nervous system.

Hydrocodone, on the other hand, is primarily an opioid that acts on the mu-opioid receptors in the central nervous system to relieve pain. While opioids can be effective for certain types of acute pain, they are generally not considered first-line treatments for neuropathic pain. Their efficacy in this specific condition is limited compared to medications that directly address nerve dysfunction, making it less suitable as a common treatment option for neuropathic pain. Thus, it is identified as the correct response to the question regarding which option is not a common